The prevalence of onychomycosis in psoriatic patients: A systematic review

Journal of the European Academy of Dermatology and Venereology

Volumn 28, Issue 5, 2014, Pages 533-541

  Klaassen, K M G ^a   Dulak, M G ^b   Van De Kerkhof, P C M ^a   Pasch, M C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CYCLOHEXIMIDE; GENTAMICIN; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; PENICILLIN G POTASSIUM; STREPTOMYCIN;

CHECKLIST; COCHRANE LIBRARY; CONTROLLED CLINICAL TRIAL (TOPIC); DERMATOPHYTE; EMBASE; EXTERNAL VALIDITY; HUMAN; MEDICAL SUBJECT HEADINGS; MEDLINE; NAIL PSORIASIS; OBSERVATIONAL STUDY; ONYCHOMYCOSIS; PERIODIC ACID SCHIFF STAIN; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SYSTEMATIC REVIEW; COMPLICATION; PSORIASIS;

HUMANS; ONYCHOMYCOSIS; PREVALENCE; PSORIASIS;

EID: 84899052352     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/jdv.12239     Document Type: Review

References (44)

1. Reich K,. Approach to managing patients with nail psoriasis. J Eur Acad Dermatol Venereol 2009; 23: 15-21.
2. Jiaravuthisan MM, Sasseville D, Vender RB, Murphy F, Muhn CY,. Psoriasis of the nail: anatomy, pathology, clinical presentation, and a review of the literature on therapy. J Am Acad Dermatol 2007; 57: 1-27.
3. de Jong EM, Seegers BA, Gulinck MK, Boezeman JB, van de Kerkhof PC,. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1,728 patients. Dermatology 1996; 193: 300-303.
4. Lawry M,. Biological therapy and nail psoriasis. Dermatol Ther 2007; 20: 60-67.
5. Armesto S, Esteve A, Coto-Segura P, et al,. Nail psoriasis in individuals with psoriasis vulgaris: a study of 661 patients. Actas Dermosifiliogr 2011; 102: 365-372.
6. Langley RG, Dauden E,. Treatment and management of psoriasis with nail involvement: a focus on biologic therapy. Dermatology 2010; 221: 29-42.
7. Klaassen KM, van de Kerkhof PC, Pasch MC,. Nail psoriasis: a questionnaire-based survey. Br J Dermatol 2013. doi: 10.1111/bjd.12354. [Epub ahead of print].
8. Williams HC,. The epidemiology of onychomycosis in Britain. Br J Dermatol 1993; 129: 101-109.
9. Szepietowski JC, Salomon J,. Do fungi play a role in psoriatic nails? Mycoses 2007; 50: 437-442.
10. Elewski BE,. Onychomycosis: pathogenesis, diagnosis, and management. Clin Microbiol Rev 1998; 11: 415-429.
11. Larsen GK, Haedersdal M, Svejgaard EL,. The prevalence of onychomycosis in patients with psoriasis and other skin diseases. Acta Derm Venereol 2003; 83: 206-209.
12. Ellis DH, Watson AB, Marley JE, Williams TG,. Non-dermatophytes in onychomycosis of the toenails. Br J Dermatol 1997; 136: 490-493.
13. Stander H, Stander M, Nolting S,. [ Incidence of fungal involvement in nail psoriasis ]. Hautarzt 2001; 52: 418-422.
14. Zisova L, Valtchev V, Sotiriou E, Gospodinov D, Mateev G,. Onychomycosis in patients with psoriasis-a multicentre study. Mycoses 2012; 55: 143-147.
15. Gupta AK, Lynde CW, Jain HC, et al,. A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre study. Br J Dermatol 1997; 136: 786-789.
16. Szepes E,. Mycotic infections of psoriatic nails. Mykosen 1986; 29: 82-84.
17. von Elm E, Altman DG, Egger M, et al,. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
18. Hamnerius N, Berglund J, Faergemann J,. Pedal dermatophyte infection in psoriasis. Br J Dermatol 2004; 150: 1125-1128.
19. Leibovici V, Hershko K, Ingber A, Westerman M, Leviatan-Strauss N, Hochberg M,. Increased prevalence of onychomycosis among psoriatic patients in Israel. Acta Derm Venereol 2008; 88: 31-33.
20. Kacar N, Ergin S, Ergin C, Erdogan BS, Kaleli I,. The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial. Clin Exp Dermatol 2007; 32: 1-5.
21. Pawlaczyk M, Rokowska A, Chmielewska I, et al,. Does onychomycosis more frequently affect patients suffering from psoriasis? Mikologia Lekarska 2007; 14: 52-55.
22. Staberg B, Gammeltoft M, Onsberg P,. Onychomycosis in patients with psoriasis. Acta Derm Venereol 1983; 63: 436-438.
23. Zawirska A, Adamski Z, Kurek L,. Dermatophyte infections in psoriatic patients. Mikologia Lekarska 2006; 13: 287-290.
24. Malka N, Contet-Audonneau N, Reichert-Penetrat S, Truchetet F, Barbaud A, Schmutz JL,. Onychomycosis and nail psoriasis. J Mycol Med 1998; 8: 192-195.
25. Sanderson S, Tatt ID, Higgins JP,. Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. Int J Epidemiol 2007; 36: 666-676.
26. Mallen C, Peat G, Croft P,. Quality assessment of observational studies is not commonplace in systematic reviews. J Clin Epidemiol 2006; 59: 765-769.
27. Salomon J, Szepietowski JC, Proniewicz A,. Are psoriatic nails predisposed to fungal infection? Korean J Med Mycol 2003; 8: 43-47.
28. Czarnecka A, Hryncewicz-Gwozdz A, Plomer-Niezgoda E, Kolodziej T,. Analysis of risk of onychomycosis in psoriatic patients. Mikologia Lekarska 2008; 15: 213-215.
29. Gupta AK, Jain HC, Lynde CW, Macdonald P, Cooper EA, Summerbell RC,. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: a multicenter canadian survey of 15,000 patients. J Am Acad Dermatol 2000; 43: 244-248.
30. Heikkila H, Stubb S,. The prevalence of onychomycosis in Finland. Br J Dermatol 1995; 133: 699-703.
31. Bramono K, Budimulja U,. Epidemiology of onychomycosis in Indonesia: data obtained from three individual studies. Nihon Ishinkin Gakkai Zasshi 2005; 46: 171-176.
32. Burzykowski T, Molenberghs G, Abeck D, et al,. High prevalence of foot diseases in Europe: results of the Achilles Project. Mycoses 2003; 46: 496-505.
33. Tchernev G, Penev PK, Nenoff P, et al,. Onychomycosis: modern diagnostic and treatment approaches. Wien Med Wochenschr 2013; 163: 1-12.
34. Sanchez-Regana ML, Videla S, Villoria J, et al,. Prevalence of fungal involvement in a series of patients with nail psoriasis. Clin Exp Dermatol 2008; 33: 194-195.
35. Dorschner RA, Lopez-Garcia B, Massie J, Kim C, Gallo RL,. Innate immune defense of the nail unit by antimicrobial peptides. J Am Acad Dermatol 2004; 50: 343-348.
36. Palatsi R, Hagg P,. The immune response against microbial infections in the skin-weak in atopic dermatitis and strong in psoriasis. Duodecim 2011; 127: 127-134.
37. Dawber RP, Samman PD, Bottoms E,. Fingernail growth in idiopathic and psoriatic onycholysis. Br J Dermatol 1971; 85: 558-560.
38. Baran R,. The burden of nail psoriasis: an introduction. Dermatology 2010; 221: 1-5.
39. Roberts DT,. Prevalence of dermatophyte onychomycosis in the United Kingdom: results of an omnibus survey. Br J Dermatol 1992; 126: 23-27.
40. Hay R,. Literature review. Onychomycosis. J Eur Acad Dermatol Venereol 2005; 19: 1-7.
41. Souza LK, Fernandes OF, Passos XS, Costa CR, Lemos JA, Silva MR,. Epidemiological and mycological data of onychomycosis in Goiania, Brazil. Mycoses 2010; 53: 68-71.
42. Gupta AK, Jain HC, Lynde CW, Watteel GN, Summerbell RC,. Prevalence and epidemiology of unsuspected onychomycosis in patients visiting dermatologists' offices in Ontario, Canada-a multicenter survey of 2001 patients. Int J Dermatol 1997; 36: 783-787.
43. Mugge C, Haustein UF, Nenoff P,. Causative agents of onychomycosis-a retrospective study. J Dtsch Dermatol Ges 2006; 4: 218-228.
44. Zaias N,. Psoriasis of the nail. A clinical-pathologic study. Arch Dermatol 1969; 99: 567-579.